Authors


Jason Broderick

Latest:

Nivolumab/Chemo Shows Lasting Benefit in Advanced Gastroesophageal Cancers

Five-year data shows lasting benefit for patients with advanced gastroesophageal cancers treated with nivolumab and chemotherapy.


Mary B. Daly, MD, PhD

Latest:

Dr. Mary B. Daly on When to Screen Patients With a Family History of Cancer

Mary B. Daly, MD, PhD, from Fox Chase Cancer Center, discusses the proper timing for screening patients with a family history of cancer.


Donna Clark, RN, BSN, OCN

Latest:

Medical Aid in Dying in the 50th State

Hawaii recently allowed medical aid in dying for patients with terminal diseases, and other states may soon follow suit.


Cathy Belt, RN, MSN, AOCN

Latest:

Cathy Belt on How to Act on Inherited Cancer Symptoms

Cathy Belt, RN, MSN, AOCN, Abramson Cancer Center of the University of Pennsylvania, discusses possible steps individuals can take upon finding out they have an inherited cancer syndrome, such as mutations in the BRCA1 or BRCA2 genes.


Stephanie Gilbertson-White, PhD, APRN-BC

Latest:

Stephanie Gilbertson-White on Palliative Care for Advanced Cancer Patients

Stephanie Gilbertson-White, PhD, APRN-BC, assistant professor, University of Iowa College of Nursing, discusses a pilot study that evaluated performance status, quality of life and survival in patients with advanced cancer who were referred to palliative care.


Colleen Castelein, AOCNP

Latest:

Managing Sickle Cell Disease: Lessons From Our Comprehensive Cancer Center

What group of our patients is diagnosed with a devastating illness in early childhood which gets increasingly worse with age and leads to debilitating pain which is both chronic and acute in nature?


Laura Panjwani

Latest:

Tumor Treating Fields Improve Survival in Glioblastoma

Optune, a noninvasive device that delivers tumor-treating fields to the brain, had been found to improve efficacy compared to chemotherapy and is well-tolerated by patients with glioblastoma multiforme (GBM).


Jennifer Wenzel, PhD, RN, CCN, FAAN

Latest:

Jennifer Wenzel on the Importance of Including Minority Patients in Clinical Trials

Jennifer Wenzel, PhD, RN, CCN, FAAN, discusses the importance of including minority patients in clinical trials


Charles Loprinzi, MD

Latest:

Hot Flash Treatment Strategies for Patients With Breast Cancer

Ahead of his presentation at the 39th Annual Miami Breast Cancer Conference, Charles L. Loprinzi, MD, highlights some non-estrogenic approaches to hot flash management for patients with breast cancer.


Laura Wood, RN, MSN, OCN

Latest:

Optimizing RCC Treatment: Integrating Patient-Reported Outcomes and Clinician Insights

Experts discuss optimizing renal cell carcinoma (RCC) treatment by integrating patient-reported outcomes and clinician insights.


Melisa Wong, MD

Latest:

Melisa Wong Points Out Potential Age Bias in Active Treatment of Lung Cancer

Melisa Wong lays out the findings of a study she did looking at the age of patients with recurrent lung cancer and the likelihood they were to receive active treatment.


William Strauss, MD

Latest:

Dr. Strauss on Mitigating Oral Mucositis Symptoms

William Strauss, MD, Executive Director, Medical Affairs, AMAG Pharmaceuticals, Inc., discusses a study that analyzed mitigating oral mucositis symptoms in patients with head and neck cancers being treated with chemoradiation therapy.


Hope S. Rugo, MD

Latest:

Oncology Nurses Are a 'Lifeline for Management' in Cancer Care

Oncology nurses are crucial in the management of cancer symptoms and treatment-related adverse events.


Anne Llewellyn, RN-BC, MS, BHSA, CCM, CRRN

Latest:

Nurses Taking Charge: Leading Change, Advancing Health

Regina Cunningham, PhD, RN, NEA-BC, FAAN, discusses her career journey, which led her to become CEO of the Hospital of the University of Pennsylvania, and shares insights on how nurses can leverage their unique skills to assume leadership roles in healthcare.


Gina Columbus

Latest:

FDA Approves Belantamab Mafodotin-blmf to Treat R/R Multiple Myeloma

The FDA has approved belantamab mafodotin-blmf (Blenrep) as a treatment for patients with relapsed/refractory multiple myeloma who have received 4 prior therapies, including an immunomodulatory drug, a proteasome inhibitor, and an anti-CD38 antibody.


Jason J. Luke, MD

Latest:

Dr. Luke on the Nurse's Role in Managing Melanoma Toxicities

Jason J. Luke, MD, an instructor in medicine atHarvard Medical School and a Medical Oncologist at the Dana-Farber Cancer Institute, explains why oncology nurses have such an important role in managing melanoma toxicities.


Reynaldo Garcia, RN, OCN

Latest:

Reynaldo Garcia on CML BCR-ABL Testing

Reynaldo Garcia From Lineberger Comprehensive Cancer Center on CML BCR-ABL Testing Recommendation



Heidi Donovan, PhD, RN

Latest:

Systematic, Adaptable Symptom Management Is Long Overdue In Oncology Practice

Heidi Donovan, PhD, RN, comments on principles of symptom management that she believes need to be better implemented in clinical practice—particularly for patients with ovarian cancer.


Ted Okon

Latest:

Abuse of 340B Program Impacts Patient Care

Inadequate oversight has distorted the noble intent of the 340B Drug Pricing Program, transforming it into a perverse profit generator for many of America’s tax-exempt hospitals.


Jessica Hergert

Latest:

Updated NCCN Guidelines Now Include Neratinib for HER2+ Breast Cancer

The update is in agreement with the FDA approval of a labeling supplement in June 2021 to the United States Prescribing Information for neratinib in HER2-positive breast cancer.


Anees Chagpar, MD

Latest:

Anees Chagpar Outlines Important Questions Nurses Should Ask Patients

Anees Chagpar describes the oncology nurse's relationship between the patient and physician and gives some examples of important questions to be asking.


Carrie Stricker, PhD, RN

Latest:

Carrie Stricker on the Efficacy of Survivorship Care Plans

Carrie Stricker from the Abramson Cancer Center of the University of Pennsylvania on the Efficacy of Survivorship Care Plans for Posttreatment Breast Cancer Survivors.


Hani Sbitany, MD

Latest:

New Lymphedema Treatment Generates Excitement

A new surgical method could help treat lymphedema, according to one expert.


Sabrina Mikan, PhD, RN, ACNS-BC

Latest:

Sabrina Mikan on the Importance of Measuring Sleep

Sabrina Mikan, PhD, RN, ACNS-BC, of Texas Oncology discusses the importance of measuring the sleep quality of patients and caregivers.


Alexander N. Shoushtari, MD

Latest:

First-in-Human Trial for Tebentafusp In Advanced Melanoma Shows Promising Safety Profile

The first-in-human trial for tebentafusp findings are in, and they show promise for managing a patients side effects to it.


Amanda Yopp

Latest:

Amanda Yopp Discusses the Challenges With Treating Multiple Myeloma Patients

Amanda Yopp, NP, Clinical Nurse Educator, Takeda Oncology, discusses the challenges with treating patients with multiple myeloma.


Timothy Clyne, RN

Latest:

Timothy Clyne on the COMFORT Curriculum and End-of-Life Discussions

Timothy Clyne, RN, Trinitas Regional Medical Center, discusses the COMFORT curriculum and end-of-life conversations.


Ishwaria Mohan Subbiah, MD

Latest:

Ishwaria Subbiah on Elderly Patients Enrolling in Clinical Trials

Ishwaria Mohan Subbiah, MD, of MD Anderson Cancer Center, discusses the importance of elderly patients enrolling in clinical trials. Ishwaria Mohan Subbiah, MD, MD Anderson Cancer Center, discusses the importance of elderly patients enrolling in clinical trials.


Kathleen M. Madden, MSN, FNP-BC, AOCNP®, APHN

Latest:

Kathleen M. Madden Provides an Overview of Targeted Therapies for Melanoma Patients

Kathleen M. Madden, MSN, FNP-BC, AOCNP®, provides an overview of treatment of melanoma with new targeted therapies.